1Evans PC,Gray JJ,Wreghitt TG,et al.Comparison of three PCR techniques for detecting cytomegalovirus (CMV) DNA in serum,detection of early antigen fluorescent foci and culture for the diagnosis of CMV infection.J Med Mierobiol,1999,48:1029-1035.
3Hazar V,Ugur A,Colak D,et al.Cytomegalovirus antigenemia and outcomes of patients undergoing allngeneic peripheral blood stem cell transplantation:effects of long-term high-dose acyclovir prophylaxis and preemptive ganeielovir treatment.Jpn J Infect Dis,2006,59:216-221.
4Boeckh M,Cooley TA,Myerson D,et al.Cytomegalovirus pp65 antigenemia-guided early treatment with ganeielovir versus ganciclovir at engraftment after allogeneic marrow transplantation:a randomized double-blind study.Blood,1996,88:4063-4071.
5[2]Machado CM,Dulley FL,Vilas Boas LS, et al. CMV pneumonia in allogeneic BMT recipients undergoing early early treatment or pre-emptive ganciclovir therapy[J]. Bone Marrow Transplantation, 2000,26:413-417.
6[3]Trenschel R, Ross S, Husing J,et al. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT[J]. Bone Marrow Transplantation, 2000,25:665-672.
7[4]Mori T, Okamoto S,Matsuoka S, et al. Risk-adapted preemptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation[J]. Bone Marrow Transplantation, 2000,25:765-769.
9Caver J,Middleton P G,Segall M,et al.Recipient TNF-α and IL-10 gene polemorphisms associate with early mortality and acute GVHD severity in HLA matched sibling BMT[J].Blood,1999,94(7):3641-3946.
10Lin M T,Storer B,Martin P J,et al.Ralation of an interleukn-10 prom other polyorphism to grart-versus-host disease and survival after hem atopoietic-cell transpiantation[J].N Engl J Med,2003,349(9):2201-2210.
